Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
510
-
Total shares
-
78M
-
Shares change
-
-3.46M
-
Total reported value, excl. options
-
$9.15B
-
Value change
-
-$401M
-
Put/Call ratio
-
1.64
-
Number of buys
-
209
-
Number of sells
-
-233
-
Price
-
$117.27
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q4 2016
519 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q4 2016.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 510 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78M shares
of 80.8M outstanding shares and own 96.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.17M shares), BAMCO INC /NY/ (5.69M shares), Fundsmith LLP (4.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.43M shares), BlackRock Fund Advisors (3.71M shares), BlackRock Institutional Trust Company, N.A. (3.26M shares), STATE STREET CORP (2.82M shares), Neuberger Berman Group LLC (2.27M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (2.22M shares), and BLAIR WILLIAM & CO/IL (2.12M shares).
This table shows the top 510 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.